Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05706935 · ClinicalTrials.gov registry record
MeMed BV® Test Evaluation in Adult Emergency Department Patients
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 111
- Enrollment target
NCT05706935: Completed study, sponsored by University of Wisconsin, Madison.
NCT05706935 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 111 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05706935 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 111 participants
- Enrollment target
Study Summary
The goal of this observational study is to compare the results of a serum biomarker called the MeMed BV®, which is approved to help differentiate between bacterial and viral respiratory infections, to clinical diagnoses of adult emergency department patients presenting with recent fever and signs or symptoms of a respiratory infection. Active participation is completed during the emergency department visit and includes drawing blood, obtaining a sputum sample, and answering survey questions.
Primary Outcome
Percent agreement between result of MeMed BV® test (bacterial or viral respiratory infection) and antibiotic prescribing by emergency medicine doctor (which implies suspected bacterial infection)
Interventions
- DIAGNOSTIC_TEST MeMed BV® test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2023-02-06 |
| Est. Completion | 2024-01-31 |
What the finished NCT05706935 record still lists
NCT05706935 is an observational study that tracks outcomes without assigning an intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which MeMed BV® test is the first listed.
NCT05706935 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05706935 about?
NCT05706935 is a clinical study titled "MeMed BV® Test Evaluation in Adult Emergency Department Patients". The goal of this observational study is to compare the results of a serum biomarker called the MeMed BV®, which is approved to help differentiate between bacterial and viral respiratory infections, to clinical diagnoses of adult emergency department patients presenting with recent fever and signs or...
What is the current status of trial NCT05706935?
This trial is currently completed. The enrollment target is 111 participants. The study started on 2023-02-06. Estimated completion is 2024-01-31.
What interventions are being tested in trial NCT05706935?
The interventions under investigation include: MeMed BV® test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05706935?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03875716 · 111 participants · NA
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
- NCT04693468 · 111 participants · Phase 1
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
- NCT05263050 · 111 participants · Phase 2
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- NCT05600842 · 111 participants
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI